Narrative
Research at the University of Manchester (UoM) has, and continues to have, a direct impact on pharmacy policy and practice. From 1993, our work on the contribution of pharmacists to primary health care has helped improve patients’ access to medicines and pharmacies. Our ‘Care@TheChemist’ trial led to changes in the national pharmaceutical contract and now almost 5,000 pharmacies offer the service to several million primary care patients. Our skill mix research is used to inform regulatory control of pharmacies and our wider workforce research continues to inform national governments about how to forecast future requirements for pharmacist numbers| Impact date | 2014 |
|---|---|
| Category of impact | Health impacts |
| Impact level | Benefit |
Related content
-
Research output
-
Workload in community pharmacies in the UK and its impact on patient safety and pharmacists' well-being: A review of the evidence
Research output: Contribution to journal › Article › peer-review
-
Changes to supervision in community pharmacy: Pharmacist and pharmacy support staff views
Research output: Contribution to journal › Article › peer-review
-
Managing demand: Transfer of management of self limiting conditions from general practice to community pharmacies
Research output: Contribution to journal › Article › peer-review
-
Affordability of medicines and patients' cost-reducing behaviour: Empirical evidence based on SUR estimates from italy and the UK
Research output: Contribution to journal › Article › peer-review
-
A pathway to the GP: The pharmaceutical 'consultation' as a first port of call in primary health care
Research output: Contribution to journal › Article › peer-review
-
Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: A multi-method study
Research output: Contribution to journal › Article › peer-review